XAGE Longevity Health Holdings Earnings per share growth rate in current year

Longevity Health Holdings attracts investors through exclusive regeneration formulas and high customer loyalty, which guarantees a stable income. The GURU.Markets platform reports the percentage change in earnings per share compared to last year, where the indicator level is 0.00. Plasma technologies support this growth, although regulatory oversight and marketing expenses create certain business risks.
Comprehensive metric breakdowns and analytics for Carmell Therapeutics (XAGE)

Longevity Health Holdings integrates cutting-edge biochemical developments into commercial beauty products, converting scientific capital into financial results. The earnings per share trend reflects the efficiency of this conversion, measuring the percentage deviation of current net income from the previous year's figures. By analyzing the year-over-year volatility of earnings per share, an investor can promptly detect a cooling of growth rates and avoid overpaying for an overheated asset.